These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 32329540)

  • 1. Hepatocellular carcinoma with glycogen storage disease type 1a.
    Okata Y; Hatakeyama T; Bitoh Y; Aida Y; Yuichiro T
    Pediatr Int; 2020 Jun; 62(6):744-745. PubMed ID: 32329540
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple adenomas and hepatocellular carcinoma in a renal transplant patient with glycogen storage disease type 1a (von Gierke disease).
    Gossmann J; Scheuermann EH; Frilling A; Geiger H; Dietrich CF
    Transplantation; 2001 Jul; 72(2):343-4. PubMed ID: 11477366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abdominal imaging findings of a patient with hepatocellular carcinoma associated with glycogen storage disease type 1a.
    Ochi H; Hiraoka A; Uehara T; Hidaka S; Kawasaki H; Furuya K; Hirooka M; Abe M; Matsuura B; Hiasa Y; Onji M; Michitaka K
    Intern Med; 2011; 50(20):2317-22. PubMed ID: 22001457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discussion regarding the method of screening for hepatocellular carcinoma in glycogen storage disease type 1a.
    Ochi H; Hiraoka A; Michitaka K
    Intern Med; 2012; 51(13):1813. PubMed ID: 22790157
    [No Abstract]   [Full Text] [Related]  

  • 5. Challenges in screening for hepatocellular carcinoma in the glycogen storage disease type 1a population.
    Bashir MR; Merkle EM; Kishnani PS
    Intern Med; 2012; 51(13):1811. PubMed ID: 22790156
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case of hepatocellular carcinoma in type I a glycogen storage disease].
    Nakamura T; Tamakoshi K; Kitagawa M; Takehira Y; Yamada M; Matsushita M; Kawamura K; Takagi M; Murohisa B; Kida H; Oota D; Ozawa T; Kawasaki T; Tsugiki M
    Nihon Shokakibyo Gakkai Zasshi; 1997 Dec; 94(12):866-70. PubMed ID: 9436397
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hepatic adenoma and hepatocellular carcinoma in 3 brothers with type I glycogenosis].
    Kharsa G; Degott C; Filoche B; Hedde JP; Potet F; Benhamou JP
    Gastroenterol Clin Biol; 1990; 14(1):84-9. PubMed ID: 2155841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the best staging system for hepatocellular carcinoma?
    Kudo M
    J Gastroenterol; 2006 Mar; 41(3):290-1. PubMed ID: 16699867
    [No Abstract]   [Full Text] [Related]  

  • 9. [A case of glycogen storage disease type I with hepatocellular carcinoma].
    Okuda Y; Ota H; Mikami K; Nagase H; Mukai R; Okada K; Ide Y; Yanagisawa T; Maruyama K; Murata K; Yokouchi H; Nagase A; Tamai M; Kinuta M
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2362-4. PubMed ID: 20037423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated PIVKA-II is associated with early recurrence and poor prognosis in BCLC 0-A hepatocellular carcinomas.
    Wang BL; Tan QW; Gao XH; Wu J; Guo W
    Asian Pac J Cancer Prev; 2014; 15(16):6673-8. PubMed ID: 25169507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of serum PIVKA-II levels for BCLC early hepatocellular carcinoma and correlation with HBV DNA.
    Wu J; Xiang Z; Bai L; He L; Tan L; Hu M; Ren Y
    Cancer Biomark; 2018; 23(2):235-242. PubMed ID: 30103302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter study on PIVKA reference interval of healthy population and establishment of PIVKA cutoff value for hepatocellular carcinoma diagnosis in China.
    Qin X; Tang G; Gao R; Guo Z; Liu Z; Yu S; Chen M; Tao Z; Li S; Liu M; Wang L; Hou L; Xia L; Cheng X; Han J; Qiu L
    Int J Lab Hematol; 2017 Aug; 39(4):392-401. PubMed ID: 28318145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative tumor marker doubling time is a useful predictor of recurrence and prognosis after hepatic resection of hepatocellular carcinoma.
    Masuda T; Beppu T; Horino K; Komori H; Hayashi H; Okabe H; Otao R; Horlad H; Ishiko T; Takamori H; Kikuchi K; Baba H
    J Surg Oncol; 2010 Oct; 102(5):490-6. PubMed ID: 19937994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of PIVKA-II After Living-donor Liver Transplantation for Hepatocellular Carcinoma.
    Park MS; Lee KW; Kim H; Choi YR; Hong G; Yi NJ; Suh KS
    Transplant Proc; 2017 Jun; 49(5):1109-1113. PubMed ID: 28583537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
    Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
    World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological Characteristics of Hepatocellular Carcinoma with Microscopic Portal Venous Invasion and the Role of Anatomical Liver Resection in These Cases.
    Shimada S; Kamiyama T; Yokoo H; Orimo T; Wakayama K; Einama T; Kakisaka T; Kamachi H; Taketomi A
    World J Surg; 2017 Aug; 41(8):2087-2094. PubMed ID: 28271260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Des-gamma-carboxy prothrombin (DCP) ratio, a novel parameter measured by monoclonal antibodies MU-3 and 19B7, as a new prognostic indicator for hepatocellular carcinoma.
    Sugimoto H; Takeda S; Inoue S; Kaneko T; Watanabe K; Nakao A
    Liver Int; 2003 Feb; 23(1):38-44. PubMed ID: 12640726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal plasma prothrombin (PIVKA-II) levels in hepatocellular carcinoma.
    Kawaguchi Y
    Jpn J Surg; 1989 May; 19(3):296-300. PubMed ID: 2550692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: two case reports.
    Manzia TM; Angelico R; Toti L; Cillis A; Ciano P; Orlando G; Anselmo A; Angelico M; Tisone G
    Transplant Proc; 2011 May; 43(4):1181-3. PubMed ID: 21620082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple hepatocellular adenomas in a patient with glycogen storage disease type I: various enhancement patterns in MRI with Gd-EOB-DTPA.
    Sakamoto A; Hayashi H; Sakamoto I; Isomoto I; Eguchi S; Takatsuki M; Kanematsu T; Abe K; Hayashi T; Uetani M
    Abdom Imaging; 2012 Apr; 37(2):239-43. PubMed ID: 21416130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.